Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.41 |
| ▸ | NMT2 | O60551 | 1/20 | 0.40 |
| ▸ | NMT1 | P30419 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | FURIN | P09958 | 3/20 | 0.39 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29782532 | 0.90 | CPB2 (0.41) | CPB2NMT2NMT1FOLH1FURIN | |
| SCHEMBL30553841 | 0.90 | FOLH1 (0.46) | CPB2FOLH1FURINPCSK6SLC15A2 | |
| SCHEMBL29630356 | 0.89 | FOLH1 (0.50) | CPB2NMT2NMT1FOLH1GSR | |
| SCHEMBL29530892 | 0.89 | FURIN (0.46) | NMT2NMT1FURIN | |
| SCHEMBL31396831 | 0.88 | FURIN (0.42) | CPB2FOLH1FURIN | |
| SCHEMBL29530917 | 0.88 | GNPAT (0.43) | FOLH1 | |
| SCHEMBL29530901 | 0.88 | FOLH1 (0.51) | NMT2NMT1FOLH1FURIN | |
| SCHEMBL29557040 | 0.87 | FOLH1 (0.54) | CPB2FOLH1CTSL | |
| SCHEMBL24130548 | 0.86 | FOLH1 (0.53) | CPB2FOLH1GSRSLC15A2 | |
| SCHEMBL8759318 | 0.86 | FOLH1 (0.53) | CPB2FOLH1GSRSLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339504-A1 | CANCER VACCINE WITH USE OF COMMON CANCER ANTIGEN COCKTAIL, TCR/CAR-T CELL THERAPEUTIC, COMPANION DIAGNOSTIC METHOD, AND METHOD FOR DIAGNOSING RISK OF CANCER ONSET BY DETECTING CIRCULATING TUMOR CELLS | NATIONAL CANCER CENTER (JP) | 2025-11-06 | — | — | US | disclosed |